Rose is a managing editor at The American Journal of Managed Care® (AJMC®).
She has a BA in journalism & media studies and Spanish from Rutgers University. You can connect with Rose on LinkedIn.
Libtayo Accepted for FDA Priority Review in NSCLC With PD-L1 Expression
November 3rd 2020Regeneron’s PD-1 inhibitor Libtayo was accepted for priority FDA review for the treatment of first-line locally advanced or metastatic non–small cell lung cancer (NSCLC) with PD-L1 expression of at least 50%.
Read More
KRAS G12C Inhibitor Shows Promising Effects in NSCLC, Other Solid Tumors
October 29th 2020A pair of abstracts based on a phase 1/2 trial of adagrasib (MRTX849) a KRAS G12C inhibitor, showed promising results for patients with lung, bowel, and other solid tumors, researchers reported at the 32nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics.
Read More
Axillary Surgery Approach Impacts BCRL Risk in Breast Cancer Patients
October 28th 2020A study published in the Journal of Clinical Oncology determined that the main risk factor for breast cancer-related lymphedema in patients with positive axillary lymph nodes is the type of axillary surgery used.
Read More
Cancer Does Not Stop for COVID-19, but Reform Becomes a Challenge
October 28th 2020During a session on day 1 of the Community Oncology Alliance (COA) Virtual Payer Exchange Summit on Oncology Payment Reform, a panel of experts discussed the ways COVID-19 continues to impact cancer care and payment reform.
Read More
Dr Lucio Gordan on Telehealth and New Care Initiatives in COVID-19
October 27th 2020Lucio Gordan, MD, president and managing physician at Florida Cancer Specialists and Research Institute, discusses the impact that COVID-19 continues to have on health care delivery and payment reform initiatives as the COA Payer Exchange Summit tackles this and other issues in payment reform.
Read More
Bo Gamble Discusses Themes in Oncology Care Reform Ahead of COA Payer Exchange Summit
October 26th 2020Bo Gamble, director of Strategic Practice Initiatives for the Community Oncology Alliance (COA), previewed the COA Payer Exchange Summit on Oncology Payment Reform ahead of the 2-day virtual meeting on October 27-28, 2020.
Read More
Dr Mark Fendrick Previews VBID Panel Discussion at COA Payer Exchange Summit
October 26th 2020During the upcoming Community Oncology Alliance (COA) Payer Exchange Summit, a panel discussion on applying value-based insurance design (VBID) in oncology will explore ways in which the coronavirus disease 2019 crisis can be an opportunity for growth.
Read More